Evidence map›Paper›PMID 30429846›Full record

ArticleFrontiers in immunology2018

A

Marieke De Bruyne, Levi Hoste, Delfien J Bogaert, Lien Van den Bossche, Simon J Tavernier, Eef Parthoens, Mélanie Migaud, Deborah Konopnicki, Jean Cyr Yombi, Bart N Lambrecht and 12 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Human immunity to fungal infections.The Journal of experimental medicine · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. CARD9 in the pathogenesis of axial spondyloarthritis.Best practice & research. Clinical rheumatology · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. The role of the CBM complex in allergic inflammation and disease.The Journal of allergy and clinical immunology · 2022
    Review
  13. Article
  14. PulmonaryWorld journal of clinical cases · 2022
    Article
  15. Article
  16. CARD9 Regulation and its Role in Cardiovascular Diseases.International journal of biological sciences · 2022
    Review
  17. CARD9 Signaling, Inflammation, and Diseases.Frontiers in immunology · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 3 countries.

Marieke De BruynePrimary Immunodeficiency Research Lab, Department of Pulmonary Medicine, Centre for Primary Immunodeficiencies, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
Levi HostePrimary Immunodeficiency Research Lab, Department of Pulmonary Medicine, Centre for Primary Immunodeficiencies, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
Delfien J BogaertPrimary Immunodeficiency Research Lab, Department of Pulmonary Medicine, Centre for Primary Immunodeficiencies, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
Lien Van den BosscheLaboratory for Protein Biochemistry and Biomolecular Engineering, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
Simon J TavernierPrimary Immunodeficiency Research Lab, Department of Pulmonary Medicine, Centre for Primary Immunodeficiencies, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
Eef ParthoensVIB-UGent Center for Inflammation Research, Ghent, Belgium.
Mélanie MigaudLaboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Medical School, Imagine Institute, Paris Descartes University, Paris, France.
Deborah KonopnickiInfectious Diseases Department, Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Jean Cyr YombiDepartment of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium.
Bart N LambrechtLaboratory of Immunoregulation, VIB-UGent Center for Inflammation Research, Ghent, Belgium.
Sabine van DaeleDepartment of Pediatric Immunology and Pulmonology, Centre for Primary Immunodeficiencies, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
Ana Karina Alves de MedeirosDepartment of Dermatology, Ghent University Hospital, Ghent, Belgium.
Lieve BrochezDepartment of Dermatology, Ghent University Hospital, Ghent, Belgium.
Rudi BeyaertUnit of Molecular Signal Transduction in Inflammation, Department of Biomedical Molecular Biology, VIB-UGent Center for Inflammation Research, Ghent University, Ghent, Belgium.
Elfride De BaereCenter for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
Anne PuelLaboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Medical School, Imagine Institute, Paris Descartes University, Paris, France.
Jean-Laurent CasanovaLaboratory of Human Genetics of Infectious Diseases, INSERM UMR1163, Necker Medical School, Imagine Institute, Paris Descartes University, Paris, France.
Jean-Christophe GoffardImmunodeficiency Unit, University Hospital ULB Erasme, Brussels, Belgium.
Savvas N SavvidesLaboratory for Protein Biochemistry and Biomolecular Engineering, Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
Filomeen HaerynckPrimary Immunodeficiency Research Lab, Department of Pulmonary Medicine, Centre for Primary Immunodeficiencies, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
Jens StaalUnit of Molecular Signal Transduction in Inflammation, Department of Biomedical Molecular Biology, VIB-UGent Center for Inflammation Research, Ghent University, Ghent, Belgium.
Melissa DullaersPrimary Immunodeficiency Research Lab, Department of Pulmonary Medicine, Centre for Primary Immunodeficiencies, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
Ghent University Hospital · BEVIB-UGent Center for Inflammation Research · BEInserm · FRCentre Hospitalier Universitaire de Saint-Pierre · BECliniques Universitaires Saint-Luc · BEErasmus Hospital · BEGhent University · BEUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Founder EffectMutationSignal TransductionB-Cell CLL-Lymphoma 10 ProteinCARD Signaling Adaptor ProteinsCell LineDisease SusceptibilityFemaleGain of Function MutationHumansMaleModels, MolecularMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinNF-kappa BPedigreeProtein BindingB-Cell CLL-Lymphoma 10 ProteinBCL10 protein, humanCARD9 protein, humanCARD Signaling Adaptor ProteinsMALT1 protein, humanMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinNF-kappa BBCL10CARD9 deficiencyCBM complexfilamentfounder mutationMALT1NF-κBsignalosome

Identifiers

PMID30429846
PMCPMC6220056
OpenAlexW2898955654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.